Billeci Domenico, Marton Elisabetta, Giordan Enrico, Carraro Valentina, Ronzon Monica, Rossi Sabrina
Department of Neurosurgery, Treviso Regional Hospital, University of Padova, Treviso, Italy.
Department of Neurosurgery, Treviso Regional Hospital, University of Padova, Treviso, Italy.
J Clin Neurosci. 2017 May;39:39-44. doi: 10.1016/j.jocn.2017.02.017. Epub 2017 Mar 9.
Spindle cell oncocytoma (SCO) is a rare pituitary tumor, classified as a WHO grade I neoplasm. Due to its rarity, SCO is often preoperatively misdiagnosed as a pituitary macroadenoma. In the present study we report two recent cases of SCO, a 61-year-old male and a 65-year-old female presenting at Treviso General Hospital between March 2014 and April 2015. Tumor resection was achieved by endoscopic transsphenoidal approach but massive hemorrhagic events hampered surgery, endangering the patient's life in both cases. Both tumors featured fascicles of spindle cells with eosiniphilic cytoplasm expressing vimentin, S-100 and thyroid transcription factor-1 (TTF-1). The diagnosis of SCO was confirmed by second opinion in both cases. Extensive review of available literature, about 30 cases from 2002 to 2015, provided valuable clinical data for preoperative diagnosis and surgical removal of SCO tumors.
梭形细胞嗜酸细胞瘤(SCO)是一种罕见的垂体肿瘤,被归类为世界卫生组织I级肿瘤。由于其罕见性,SCO术前常被误诊为垂体大腺瘤。在本研究中,我们报告了两例近期的SCO病例,分别为一名61岁男性和一名65岁女性,于2014年3月至2015年4月期间就诊于特雷维索综合医院。通过内镜经蝶窦入路实现了肿瘤切除,但大量出血事件阻碍了手术,在两例中均危及患者生命。两个肿瘤均具有梭形细胞束,其嗜酸性细胞质表达波形蛋白、S-100和甲状腺转录因子-1(TTF-1)。两例病例均通过二次诊断确诊为SCO。对2002年至2015年约30例现有文献的广泛回顾,为SCO肿瘤的术前诊断和手术切除提供了有价值的临床数据。